| Variable . | AKI-normalNa (Na+ < 145 mmol/l) . | AKI-hyperNa (Na+ > 145 mmol/l) . | Total . | P value . |
|---|---|---|---|---|
| MAKE at 10 (%) | 160 (57.3) | 65 (83.3) | 225 (63.03) | 0.000a |
| Mortality (%) | 116 (41.58) | 50 (64.1) | 166 (46.5) | 0.000a |
| Decrease eGFR | 111 (39.7) | 55 (70.51) | 166 (46.5) | 0.000a |
| KRT (%) | 72 (25.8) | 31 (39.74) | 103 (28.8) | 0.016a |
| IDH | 47 (16.85) | 26 (33.3) | 73 (20.4) | 0.001a |
| PD | 5 (1.79) | 3 (3.85) | 8 (2.24) | 0.380 |
| CRRT | 20 (7.17) | 2 (2.56) | 22 (6.16) | 0.135 |
| MAKE at 30–90 (%) | 197 (70.61) | 69 (88.46) | 266 (74.51) | 0.001a |
| Mortality at 30–90 (%) | 172 (61.6) | 61 (78.21) | 233 (65.2) | 0.007a |
| Decrease GFR at 30–90 (%) | 20 (7.17) | 4 (5.13) | 24 (6.72) | 0.619 |
| KRT at 30–90 (%) | 83 (29.7) | 32 (41) | 115 (32.2) | 0.060 |
| Variable . | AKI-normalNa (Na+ < 145 mmol/l) . | AKI-hyperNa (Na+ > 145 mmol/l) . | Total . | P value . |
|---|---|---|---|---|
| MAKE at 10 (%) | 160 (57.3) | 65 (83.3) | 225 (63.03) | 0.000a |
| Mortality (%) | 116 (41.58) | 50 (64.1) | 166 (46.5) | 0.000a |
| Decrease eGFR | 111 (39.7) | 55 (70.51) | 166 (46.5) | 0.000a |
| KRT (%) | 72 (25.8) | 31 (39.74) | 103 (28.8) | 0.016a |
| IDH | 47 (16.85) | 26 (33.3) | 73 (20.4) | 0.001a |
| PD | 5 (1.79) | 3 (3.85) | 8 (2.24) | 0.380 |
| CRRT | 20 (7.17) | 2 (2.56) | 22 (6.16) | 0.135 |
| MAKE at 30–90 (%) | 197 (70.61) | 69 (88.46) | 266 (74.51) | 0.001a |
| Mortality at 30–90 (%) | 172 (61.6) | 61 (78.21) | 233 (65.2) | 0.007a |
| Decrease GFR at 30–90 (%) | 20 (7.17) | 4 (5.13) | 24 (6.72) | 0.619 |
| KRT at 30–90 (%) | 83 (29.7) | 32 (41) | 115 (32.2) | 0.060 |
Abbreviations: MAKE: major adverse kidney events. HR: Hazard ratio. LCI: lower confidence interval. UCI: upper confidence interval.
p= <0.05
| Variable . | AKI-normalNa (Na+ < 145 mmol/l) . | AKI-hyperNa (Na+ > 145 mmol/l) . | Total . | P value . |
|---|---|---|---|---|
| MAKE at 10 (%) | 160 (57.3) | 65 (83.3) | 225 (63.03) | 0.000a |
| Mortality (%) | 116 (41.58) | 50 (64.1) | 166 (46.5) | 0.000a |
| Decrease eGFR | 111 (39.7) | 55 (70.51) | 166 (46.5) | 0.000a |
| KRT (%) | 72 (25.8) | 31 (39.74) | 103 (28.8) | 0.016a |
| IDH | 47 (16.85) | 26 (33.3) | 73 (20.4) | 0.001a |
| PD | 5 (1.79) | 3 (3.85) | 8 (2.24) | 0.380 |
| CRRT | 20 (7.17) | 2 (2.56) | 22 (6.16) | 0.135 |
| MAKE at 30–90 (%) | 197 (70.61) | 69 (88.46) | 266 (74.51) | 0.001a |
| Mortality at 30–90 (%) | 172 (61.6) | 61 (78.21) | 233 (65.2) | 0.007a |
| Decrease GFR at 30–90 (%) | 20 (7.17) | 4 (5.13) | 24 (6.72) | 0.619 |
| KRT at 30–90 (%) | 83 (29.7) | 32 (41) | 115 (32.2) | 0.060 |
| Variable . | AKI-normalNa (Na+ < 145 mmol/l) . | AKI-hyperNa (Na+ > 145 mmol/l) . | Total . | P value . |
|---|---|---|---|---|
| MAKE at 10 (%) | 160 (57.3) | 65 (83.3) | 225 (63.03) | 0.000a |
| Mortality (%) | 116 (41.58) | 50 (64.1) | 166 (46.5) | 0.000a |
| Decrease eGFR | 111 (39.7) | 55 (70.51) | 166 (46.5) | 0.000a |
| KRT (%) | 72 (25.8) | 31 (39.74) | 103 (28.8) | 0.016a |
| IDH | 47 (16.85) | 26 (33.3) | 73 (20.4) | 0.001a |
| PD | 5 (1.79) | 3 (3.85) | 8 (2.24) | 0.380 |
| CRRT | 20 (7.17) | 2 (2.56) | 22 (6.16) | 0.135 |
| MAKE at 30–90 (%) | 197 (70.61) | 69 (88.46) | 266 (74.51) | 0.001a |
| Mortality at 30–90 (%) | 172 (61.6) | 61 (78.21) | 233 (65.2) | 0.007a |
| Decrease GFR at 30–90 (%) | 20 (7.17) | 4 (5.13) | 24 (6.72) | 0.619 |
| KRT at 30–90 (%) | 83 (29.7) | 32 (41) | 115 (32.2) | 0.060 |
Abbreviations: MAKE: major adverse kidney events. HR: Hazard ratio. LCI: lower confidence interval. UCI: upper confidence interval.
p= <0.05
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
